LncHDAC2 is highly expressed in CD13+CD133+ cells, which promotes LCSC self-renewal and tumor progression by recruiting NuRD complex binding to the promoter of PTCH1, leading to inhibition of transcriptional activity and subsequent activation of Hh signaling [193]. The gene discussed is PROM1; the disease is neoplasm.